Srikumar P Chellappan
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 25, 2022
HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma.Sathya Neelature Sriramareddy, Fernanda Faião-Flores, Michael F Emmons
|Aug 07, 2021
Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells.Jaya Padmanabhan, Biswarup Saha, Chase Powell
|Mar 15, 2020
Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2.Namrata Bora-Singhal, Durairaj Mohankumar, Biswarup Saha
|Jun 23, 2019
HDAC Inhibition Enhances the <i>In Vivo</i> Efficacy of MEK Inhibitor Therapy in Uveal Melanoma.Fernanda Faião-Flores, Michael F Emmons, Michael A Durante
|May 19, 2019
Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC.Marwa Alhothali, Mevin Mathew, Geeta Iyer
|Dec 15, 2015
Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis.Smitha Pillai, Jonathan Nguyen, Joseph Johnson
Pageof 1
Frequent Collaborators
2 joint publications
Jonathan D Licht
2 joint publications
Michael A Durante
1 joint publications
Jonathan Nguyen
1 joint publications
Biswarup Saha
1 joint publications
Qianxing Mo
1 joint publications
Sathya Neelature Sriramareddy
1 joint publications
Keiran S M Smalley
1 joint publications
John M Koomen
1 joint publications
J William Harbour
